This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana (HUM), Northwell Tie Up for Better Health Outcome
by Zacks Equity Research
Humana (HUM) partners with Northwell to provide improved healthcare services in the New York metropolitan region.
Cigna (CI) Rides on a Diversified Business, Capital Position
by Zacks Equity Research
Cigna's (CI) prolific business profile and a solid balance sheet position poise it well for long-term growth.
Molina Healthcare's (MOH) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results reflect higher revenues and membership.
Molina (MOH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 53.43% and 3.68%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Molina (MOH) Q3 Earnings Expected to Decline
by Zacks Equity Research
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana (HUM) Expands in Tennessee to Boost Medicare Business
by Zacks Equity Research
Humana (HUM) expands Medicare Advantage in 31 rural counties of the Knoxville, Memphis, Nashville regions as well as drives benefits for veterans.
Humana Adds Retail Pharmacies to Medicare Part D Network
by Zacks Equity Research
Humana (HUM) adds Kroger Health and its chain of pharmacies to its preferred stand-alone Medicare Part D pharmacy network, to be effective 2021.
Humana's (HUM) MA Members Gain From Better Health Outcomes
by Zacks Equity Research
Humana's (HUM) individual Medicare Advantage patients enjoy value-based heathcare at reasonable costs.
Humana, FMCNA Expand Services for Better Health Outcomes
by Zacks Equity Research
Humana (HUM) expands agreement with Fresenius Medical Care North America to provide better healthcare for Humana Medicare Advantage and commercial members with CKD and ESRD.
Humana Ties Up to Offer Better Healthcare in Colorado Springs
by Zacks Equity Research
Humana (HUM) partners Centura Health in Colorado Springs to dispense high-quality in-network medical care for Humana Medicare Advantage members.
Humana Ties Up to Provide Improved Healthcare in Chicago
by Zacks Equity Research
Humana (HUM) partners Rush Health to offer in-network medical care in the Chicago region for Humana Medicare Advantage members.
Molina Healthcare to Buy Affinity Health Plan for $380 Million
by Zacks Equity Research
Molina Healthcare (MOH) to purchase Affinity Health Plan's assets to boost its capabilities and enhance its portfolio in the process.
Humana Ties Up to Provide Improved Medical Care in Ohio
by Zacks Equity Research
Humana (HUM) partners The Ohio State University Wexner Medical Center to provide in-network healthcare for Humana Medicare Advantage members.
Uncertainty Over Supreme Court Ruling Weighs on Healthcare
by Zacks Equity Research
Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.
Humana (HUM) Ties Up to Boost Medicare Network in New Jersey
by Zacks Equity Research
Humana (HUM) forges partnership with AtlantiCare to enhance its presence in New Jersey as well as provide better healthcare to its members.
Here's Why You Should Hold Magellan Stock in Your Portfolio
by Zacks Equity Research
Magellan (MGLN) continues to benefit from cost-cutting initiatives and impressive capital position.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
Molina (MOH) Down 1.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
by Zacks Equity Research
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on an upbeat outlook and rising membership, Anthem (ANTM) holds immense potential to reap benefits for investors.
Solid Near-Term HMO Industry Prospects on Multiple Tailwinds
by Sapna Bagaria
Health insurers are on a solid ground, given rising demand for Medicare policies, led by the increasing baby boomer population.
3 Health Insurers That Surpass the S&P 500 Year to Date
by Srijita Guha
We zero in on three health insurers that have managed to outperform the broader index year to date, banking on core strength.
Molina Healthcare (MOH) Surges 44.1% YTD: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) rising membership is likely to boost its revenues, which in turn, might perk up in share price.
Cigna Banks on Diversified Business, Solid Capital Position
by Zacks Equity Research
Cigna's (CI) prolific business profile creates a steady revenue recovery trajectory while its solid financial footing enables reinvestment in business
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 results reflect higher revenues and membership growth.